Greenlight Capital Re Bolsa (NASDAQ: GLRE)

Últimas noticias sobre Greenlight Capital Re (NASDAQ:GLRE) Bolsa

Greenlight Capital Re

Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.

ACTU

ALVO

BACK

CSBR

EVGR

GLRE

HEPA

JDZG

JYNT

LUNG

PRTA

SRRK

UNTY

VREX

YIBO

ZKIN

IMAC Holdings sube más del 108% tras anunciar Ignite Proteomics. Conoce las acciones más destacadas en la negociación previa.

Acciones de IMAC Holdings se disparan un 108%; 20 acciones en movimiento en el premercado de EE.UU.

Greenlight Reinsurance, Ltd. - Class A Ordinary Shares

Greenlight Capital Re Ltd

Earnings

News

Greenlight Capital Re Q4 2024 GAAP EPS $(0.81) Down From $0.50 YoY, Gross Premiums Written Increased 28% To $143.8M

<h3>Companies Reporting Before The Bell</h3>
• Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) is expected to report quarterly earnings at $0.89 per share on revenue of $305.85 million. 
• BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $1.15 billion. 
• UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) is estimated to report quarterly loss at $0.72 per share on revenue of $25.25 million. 
• DarioHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIO#NASDAQ">DRIO</a>) is expected to report quarterly loss at $0.14 per share on revenue of $7.39 million. 
• Fennec Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $16.42 million. 
• Optical Cable (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCC#NASDAQ">OCC</a>) is estimated to report earnings for its first quarter. 
• Cohen &amp; Co (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/COHN#AMEX">COHN</a>) is expected to report earnings for its fourth quarter. 
• Aligos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGS#NASDAQ">ALGS</a>) is projected to report quarterly loss at $3.67 per share on revenue of $433 thousand. 
• Genie Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNE#NYSE">GNE</a>) is estimated to report earnings for its fourth quarter. 
• Rand Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAND#NASDAQ">RAND</a>) is expected to report earnings for its fourth quarter. 
• Telos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>) is expected to report quarterly loss at $0.09 per share on revenue of $25.55 million. 
• NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) is likely to report earnings for its fourth quarter. 
• Willis Lease Finance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLFC#NASDAQ">WLFC</a>) is estimated to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Ramaco Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METCB#NASDAQ">METCB</a>) is projected to report earnings for its fourth quarter. 
• Ramaco Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $176.04 million. 
• Grupo Supervielle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUPV#NYSE">SUPV</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $215.50 million. 
• One Group Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $239.77 million. 
• NCS Multistage Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCSM#NASDAQ">NCSM</a>) is likely to report earnings for its fourth quarter. 
• Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) is projected to report quarterly loss at $0.03 per share on revenue of $1.62 million. 
• Yalla Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YALA#NYSE">YALA</a>) is projected to report earnings for its fourth quarter. 
• Douglas Elliman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOUG#NYSE">DOUG</a>) is expected to report quarterly loss at $0.08 per share on revenue of $233.65 million. 
• Great Elm Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GECC#NASDAQ">GECC</a>) is expected to report quarterly earnings at $0.35 per share on revenue of $11.46 million. 
• Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $9.90 million. 
• Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) is projected to report earnings for its fourth quarter. 
• Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) is likely to report quarterly earnings at $1.49 per share on revenue of $14.39 billion. 
• Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) is likely to report quarterly loss at $0.18 per share on revenue of $43.88 million. 
• Redwire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) is likely to report quarterly loss at $0.18 per share on revenue of $75.58 million. 
• TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) is estimated to report quarterly earnings at $0.38 per share on revenue of $84.38 million. 
• Quanex Building Prods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) is likely to report quarterly loss at $0.05 per share on revenue of $384.99 million. 
• Commercial Vehicle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGI#NASDAQ">CVGI</a>) is likely to report quarterly loss at $0.07 per share on revenue of $158.36 million. 
• Viemed Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMD#NASDAQ">VMD</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $59.40 million. 
• LifeMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFMD#NASDAQ">LFMD</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $57.34 million. 
• Seaport Entertainment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SEG#AMEX">SEG</a>) is likely to report earnings for its fourth quarter. 
• Limbach Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMB#NASDAQ">LMB</a>) is likely to report quarterly earnings at $0.77 per share on revenue of $149.37 million. 
• PLAYSTUDIOS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYPS#NASDAQ">MYPS</a>) is expected to report quarterly earnings at $0.02 per share on revenue of $67.73 million. 
• Gaia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAIA#NASDAQ">GAIA</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $23.78 million. 
• System1 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SST#NYSE">SST</a>) is expected to report quarterly loss at $0.23 per share on revenue of $91.28 million. 
• Mission Produce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVO#NASDAQ">AVO</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $272.00 million. 
• StandardAero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SARO#NYSE">SARO</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $1.37 billion. 
• Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $222.06 million. 
• HighPeak Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPK#NASDAQ">HPK</a>) is estimated to report quarterly earnings at $0.14 per share on revenue of $246.32 million. 
• PGIM ETF Trust PGIM Portfolio Ballast ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/PBL#BATS">PBL</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $147.18 million. 
• Hesai Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $121.19 million. 
• Vail Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) is projected to report quarterly earnings at $6.36 per share on revenue of $1.14 billion. 
• Mobile Infrastructure (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) is likely to report earnings for its fourth quarter. 
• Auna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUNA#NYSE">AUNA</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $296.50 million. 
• Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) is expected to report quarterly loss at $0.01 per share on revenue of $187.84 million. 
• Flotek Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTK#NYSE">FTK</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $50.08 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALGS

ASAN

AUNA

Mobile Infrastructure Corporation Common Stock

BEEP

BNTX

CHRS

COHN

CVGI

DOUG

DRIO

FENC

GAIA

GECC

HSAI

LCTX

LFMD

METC

Ramaco Resources, Inc. - Class B Common Stock

METCB

MYPS

NCSM

NPWR

ORCL

RAND

SARO

STKS

SUPV

TBRG

URGN

WLFC

YALA

Earnings Scheduled For March 10, 2025

Shares of IMAC Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BACK#NASDAQ">BACK</a>) rose sharply in today's pre-market trading after the company announced it launched Ignite Proteomics, <a href="https://www.benzinga.com/quote/BACK">its new subsidiary</a>.
IMAC shares jumped 108.6% to $1.73 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Dunxin Financial Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXF#NYSE">DXF</a>) gained 110.6% to $16.32 in pre-market trading after dipping 73% on Monday.</li>
<li>Planet Image International Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YIBO#NASDAQ">YIBO</a>) rose 85.7% to $5.72 in pre-market trading following a 43% surge on Monday.</li>
<li>ZK International Group Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZKIN#NASDAQ">ZKIN</a>) gained 47% to $0.9998 in pre-market trading after the company reported a year-over-year increase in FY24 EPS results.</li>
<li>Hepion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) gained 32.7% to $0.2191 in pre-market trading after falling 13% on Monday. Hepion Pharmaceuticals recently announced a $9 million public offering.</li>
<li>Pulmonx Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNG#NASDAQ">LUNG</a>) gained 27.2% to $8.00 in pre-market trading.</li>
<li>JIADE Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) rose 26.1% to $1.11 in pre-market trading after gaining around 18% on Monday.</li>
<li>Unity Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNTY#NASDAQ">UNTY</a>) gained 23.7% to $59.99 in pre-market trading.</li>
<li>Concentra Group Holdings Parent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CON#NYSE">CON</a>) shares jumped 14.6% to $26.99 in pre-market trading. Concentra recently announced a 5.5% increase in preliminary fourth-quarter 2024 revenue.</li>
<li>Empire Petroleum Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EP#NYSE">EP</a>) rose 8.2% to $6.50 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Evergreen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGR#NASDAQ">EVGR</a>) shares fell 58.3% to $5.00 in pre-market trading.</li>
<li>Greenlight Capital Re, Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) shares fell 49.1% to $7.00 in pre-market trading.</li>
<li>Actuate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTU#NASDAQ">ACTU</a>) dipped 41.1% to $6.00 in pre-market trading.</li>
<li>Prothena Corporation plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTA#NASDAQ">PRTA</a>) declined 31.4% to $11.01 in pre-market trading.</li>
<li>The Joint Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) fell 27.3% to $8.10 in today's pre-market trading. The Joint Corp recently announced a year-over-year increase in patient visits.</li>
<li>Varex Imaging Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) shares dipped 26% to $10.10 in pre-market trading. Varex Imaging will report unaudited financial results for the first quarter of fiscal year 2025 on Thursday, Feb. 6.</li>
<li>Champions Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) fell 22.2% to $9.10 in pre-market trading.</li>
<li>EVI Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVI#NYSE">EVI</a>) shares tumbled 13.1% to $16.20 in pre-market trading. EVI Industries recently announced plans to acquire Haiges Machinery.</li>
<li>Scholar Rock Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) fell 13% to $37.00 in pre-market trading.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) fell 9.6% to $11.81 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43230206/jim-cramer-is-worried-about-this-consumer-cyclical-stock-7-yield-something-may-be-wrong-here">Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? &#8216;Something May Be Wrong Here&#8217;</a></li>
</ul>

Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket

WIIM

Greenlight Capital Re shares are trading higher after the company reported better-than-expected Q3 financial results.

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) reported quarterly earnings of $1.01 per share which beat the analyst consensus estimate of $0.65 by 55.38 percent. This is a 158.97 percent increase over earnings of $0.39 per share from the same period last year. The company reported $188.01 million in sales this quarter. This is a 12.63 percent increase over sales of $166.92 million the same period last year.

Earnings Beats

Greenlight Capital Re Q3 EPS $1.01 Beats $0.65 Estimate, Sales $188.01M Up From $166.92M YoY

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) reported quarterly earnings of $0.23 per share which missed the analyst consensus estimate of $0.25 by 8 percent. This is a 82.58 percent decrease over earnings of $1.32 per share from the same period last year. The company reported $174.86 million in sales this quarter. This is a 7.82 percent decrease over sales of $189.69 million the same period last year.

Earnings Misses

Greenlight Capital Re Q2 GAAP EPS $0.23 Misses $0.25 Estimate, Sales $174.86M Down From $189.69M YoY

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) reported quarterly earnings of $0.78 per share which missed the analyst consensus estimate of $0.80 by 2.5 percent. This is a 358.82 percent increase over earnings of $0.17 per share from the same period last year.

Greenlight Capital Re Q1 EPS $0.78 Misses $0.80 Estimate

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) reported quarterly earnings of $0.78 per share.

Greenlight Capital Re Q1 2024 GAAP EPS $0.78

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.42 by 19.05 percent. This is a 45.05 percent decrease over earnings of $0.91 per share from the same period last year. The company reported $155.49 million in sales this quarter. This is a 6.85 percent increase over sales of $145.51 million the same period last year.

Greenlight Capital Re Q4 EPS $0.50 Beats $0.42 Estimate, Sales $155.49M Up From $145.51M YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
&bull; Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) is estimated to report quarterly earnings at $2.22 per share on revenue of $29.33 billion.
&bull; 2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) is expected to report quarterly loss at $0.99 per share on revenue of $14.71 million.
&bull; CLPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPS#NASDAQ">CLPS</a>) is expected to report earnings for its first quarter.
&bull; Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) is projected to report quarterly loss at $0.50 per share on revenue of $350 thousand.
&bull; Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $183.67 million.
&bull; Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is projected to report quarterly loss at $1.39 per share on revenue of $2.55 million.
&bull; Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) is likely to report quarterly loss at $0.36 per share on revenue of $276.94 million.
&bull; CECO Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) is likely to report quarterly earnings at $0.24 per share on revenue of $146.61 million.
&bull; 908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) is expected to report quarterly loss at $0.26 per share on revenue of $14.16 million.
&bull; Neuronetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) is projected to report quarterly loss at $0.26 per share on revenue of $19.85 million.
&bull; Broadwind (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWEN#NASDAQ">BWEN</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $50.15 million.
&bull; Global Business Travel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTG#NYSE">GBTG</a>) is projected to report quarterly loss at $0.03 per share on revenue of $541.17 million.
&bull; Riskified (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $84.02 million.
&bull; Angel Oak Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $9.00 million.
&bull; L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $129.35 million.
&bull; Rand Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAND#NASDAQ">RAND</a>) is expected to report earnings for its fourth quarter.
&bull; Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) is likely to report earnings for its fourth quarter.
&bull; Sophia Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) is projected to report quarterly loss at $0.26 per share on revenue of $17.33 million.
&bull; First Watch Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $237.53 million.
&bull; Compugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEN#NASDAQ">CGEN</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $20.00 million.
&bull; SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) is likely to report quarterly loss at $0.01 per share on revenue of $59.49 million.
&bull; Ferguson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) is estimated to report quarterly earnings at $1.85 per share on revenue of $6.77 billion.
&bull; Cipher Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $41.78 million.
&bull; Axogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) is likely to report quarterly loss at $0.10 per share on revenue of $41.65 million.
&bull; V2X (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $1.01 billion.
&bull; Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) is likely to report earnings for its fourth quarter.
&bull; Myers Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $196.19 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is estimated to report quarterly earnings at $0.80 per share on revenue of $197.70 million.
&bull; Nordstrom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) is estimated to report quarterly earnings at $0.88 per share on revenue of $4.39 billion.
&bull; BlackRock Cap Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKCC#NASDAQ">BKCC</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $20.32 million.
&bull; Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) is likely to report earnings for its fourth quarter.
&bull; Kingsway Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFS#NYSE">KFS</a>) is likely to report earnings for its fourth quarter.
&bull; Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is expected to report quarterly loss at $0.19 per share on revenue of $293.53 million.
&bull; Cumberland (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPIX#NASDAQ">CPIX</a>) is likely to report earnings for its fourth quarter.
&bull; TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) is likely to report quarterly loss at $0.08 per share on revenue of $1.00 million.
&bull; Entravision Comms (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVC#NYSE">EVC</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $308.47 million.
&bull; Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) is projected to report quarterly loss at $0.87 per share on revenue of $10.58 million.
&bull; Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) is likely to report quarterly loss at $3.66 per share on revenue of $73.50 million.
&bull; Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) is expected to report quarterly loss at $0.62 per share on revenue of $8.01 million.
&bull; Allient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNT#NASDAQ">ALNT</a>) is expected to report quarterly earnings at $0.32 per share on revenue of $132.56 million.
&bull; Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) is projected to report quarterly earnings at $0.54 per share on revenue of $329.20 million.
&bull; Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) is estimated to report earnings for its fourth quarter.
&bull; Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $34.10 million.
&bull; Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) is projected to report quarterly loss at $1.07 per share on revenue of $1.06 million.
&bull; Socket Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCKT#NASDAQ">SCKT</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $4.91 million.
&bull; Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) is expected to report quarterly loss at $0.40 per share on revenue of $1.95 million.
&bull; Park-Ohio Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKOH#NASDAQ">PKOH</a>) is likely to report quarterly earnings at $0.55 per share on revenue of $386.45 million.
&bull; W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $138.42 million.
&bull; Cadre Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDRE#NYSE">CDRE</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $121.79 million.
&bull; Semler Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $14.50 million.
&bull; Agiliti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGTI#NYSE">AGTI</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $291.41 million.
&bull; Nuvei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEI#NASDAQ">NVEI</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $319.51 million.
&bull; Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) is estimated to report quarterly earnings at $0.84 per share on revenue of $283.00 million.
&bull; Mayville Engineering (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEC#NYSE">MEC</a>) is projected to report quarterly earnings at $0.13 per share on revenue of $152.30 million.
&bull; Aquestive Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQST#NASDAQ">AQST</a>) is likely to report quarterly loss at $0.08 per share on revenue of $11.63 million.
&bull; Orthofix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) is expected to report earnings for its fourth quarter.
&bull; MeridianLink (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $74.86 million.
&bull; Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) is likely to report earnings for its fourth quarter.
&bull; Cerus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERS#NASDAQ">CERS</a>) is expected to report quarterly loss at $0.02 per share on revenue of $49.27 million.
&bull; American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $150.47 million.
&bull; Cricut (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $249.68 million.
&bull; Crexendo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $13.80 million.
&bull; Aeva Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NYSE">AEVA</a>) is likely to report quarterly loss at $0.15 per share on revenue of $1.57 million.
&bull; LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $127.21 million.
&bull; PlayAGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGS#NYSE">AGS</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $92.57 million.
&bull; Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) is likely to report quarterly loss at $0.14 per share on revenue of $63.13 million.
&bull; CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is expected to report quarterly earnings at $0.82 per share on revenue of $839.04 million.
&bull; HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $149.29 million.
&bull; Banco BBVA Argentina (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAR#NYSE">BBAR</a>) is estimated to report earnings for its fourth quarter.
&bull; NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) is expected to report quarterly loss at $0.31 per share on revenue of $17.46 million.
&bull; Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) is projected to report earnings for its fourth quarter.
&bull; Ooma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $61.46 million.
&bull; ChargePoint Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) is likely to report quarterly loss at $0.13 per share on revenue of $119.59 million.
&bull; ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) is expected to report earnings for its fourth quarter.
&bull; NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $63.35 million.
&bull; Box (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $262.95 million.
&bull; Weyco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEYS#NASDAQ">WEYS</a>) is projected to report earnings for its fourth quarter.
&bull; Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is likely to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AEVA

AGTI

ALNT

AOMR

APEI

AQST

AXGN

BASE

BBAR

BKCC

BNGO

BWEN

CDRE

CECO

CERS

CGEN

CHPT

CIFR

CLPS

CNSL

CPIX

CRCT

CRWD

CXDO

DAVE

FERG

FSTR

FWRG

GBTG

ISPO

MASS

MCRB

MLNK

MRNS

NEWT

NPCE

NUWE

NVEI

NYXH

OFIX

OOMA

PKOH

PRST

PSTV

RIGL

ROST

RSKD

SCKT

SEAT

SMLR

SMRT

SOPH

STIM

TCON

TSVT

VTOL

WEYS

Earnings Scheduled For March 5, 2024

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-03-05. Here's what investors need to know before the announcement.
Analysts estimate that Greenlight Capital Re will report an earnings per share (EPS) of $0.42. 
Greenlight Capital Re bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company beat EPS by $0.69, which was followed by a 1.93% drop in the share price the next day.
Here's a look at Greenlight Capital Re's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.30</td>
<td>0.95</td>
<td>-0.10</td>
<td>0.75</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.39</td>
<td>1.32</td>
<td>0.17</td>
<td>0.91</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>6.0%</td>
<td>-5.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709568124_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Greenlight Capital Re were trading at $12.405 as of March 01. Over the last 52-week period, shares are up 23.56%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/GLRE/earnings">To track all earnings releases for Greenlight Capital Re visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Greenlight Capital Re's Earnings: A Preview

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Fidelis Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIHL#NYSE">FIHL</a>) shares increased by 14.5% to $17.13 during Friday's regular session. As of 12:40 EST, this security is trading at a volume of 632.4K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.9 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) stock moved upwards by 12.58% to $1.61. Marpai's stock is trading at a volume of 58.8K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $12.8 million. </li>
<li>Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) stock increased by 8.17% to $0.5. Reliance Global Group's stock is trading at a volume of 140.2K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $2.2 million. </li>
<li>Hippo Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) stock increased by 6.54% to $14.97. As of 12:40 EST, Hippo Holdings's stock is trading at a volume of 209.1K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $326.5 million. </li>
<li>SelectQuote (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLQT#NYSE">SLQT</a>) stock moved upwards by 6.18% to $2.06. Trading volume for SelectQuote's stock is 817.0K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $332.9 million. </li>
<li>Kingstone Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) stock rose 5.83% to $3.99. Trading volume for this security as of 12:40 EST is 24.8K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $33.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>American Coastal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) stock decreased by 15.28% to $11.81 during Friday's regular session. American Coastal's stock is trading at a volume of 687.4K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $521.9 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>FG Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGFPP#NASDAQ">FGFPP</a>) shares fell 7.45% to $17.4. The current volume of 416 shares is 0% of FG Finl Gr's average full-day volume over the last 100 days (last updated at 12:40 EST). </li>
<li>Cheche Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCG#NASDAQ">CCG</a>) shares declined by 3.18% to $4.57. Trading volume for Cheche Group's stock is 5.2K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $362.8 million. </li>
<li>Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) shares decreased by 3.09% to $12.24. Trading volume for Greenlight Capital Re's stock is 32.6K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $446.3 million. </li>
<li>Intl General Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGIC#NASDAQ">IGIC</a>) shares declined by 2.86% to $11.9. As of 12:40 EST, this security is trading at a volume of 167.6K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $594.8 million. </li>
<li>Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) shares fell 2.63% to $60.92. Axis Capital Holdings's stock is trading at a volume of 133.6K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.2 billion. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

Trading Ideas

ACIC

FGFPP

FIHL

HIPO

IGIC

KINS

MRAI

RELI

SLQT

Insurance Stocks Moving In Friday's Intraday Session

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Huize Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUIZ#NASDAQ">HUIZ</a>) stock rose 7.49% to $0.78 during Tuesday's regular session. Trading volume for Huize Holding's stock is 14.8K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $34.0 million. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) stock increased by 5.49% to $12.59. The current volume of 7.2K shares is 0% of Crawford's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at 615241133. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) shares rose 5.3% to $13.1. As of 12:40 EST, Crawford's stock is trading at a volume of 47.8K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at 640417866. </li>
<li>Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) stock rose 2.28% to $369.19. The current volume of 280.0K shares is 0% of Everest Group's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $15.7 billion. As per the news, the Q4 earnings report came out 4 days ago. </li>
<li>Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) shares increased by 1.66% to $0.47. The current volume of 21.7K shares is 0% of Reliance Global Group's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $2.2 million. </li>
<li>RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) shares rose 0.8% to $228.05. As of 12:40 EST, this security is trading at a volume of 247.2K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $11.9 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Conifer Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNFR#NASDAQ">CNFR</a>) stock decreased by 10.15% to $1.23 during Tuesday's regular session. Conifer Holdings's stock is trading at a volume of 400 shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.3 million. </li>
<li>Maiden Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHLD#NASDAQ">MHLD</a>) stock fell 6.99% to $1.73. As of 12:40 EST, Maiden Hldgs's stock is trading at a volume of 35.3K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $187.7 million. </li>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) stock fell 6.88% to $1.22. The current volume of 23.0K shares is 0% of Marpai's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $12.3 million. </li>
<li>Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) shares declined by 5.0% to $11.42. Greenlight Capital Re's stock is trading at a volume of 39.3K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $423.3 million. </li>
<li>eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) stock fell 4.96% to $6.91. Trading volume for eHealth's stock is 61.4K as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $206.2 million. </li>
<li>Brookfield Reinsurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNRE#NYSE">BNRE</a>) shares decreased by 4.82% to $39.4. Trading volume for this security as of 12:40 EST is 451, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at 4433750398. As per the news, the Q4 earnings report came out 3 days ago. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BNRE

CNFR

EHTH

HUIZ

MHLD

Insurance Stocks Moving In Tuesday's Intraday Session

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Hippo Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) stock rose 11.54% to $10.92 during Monday's regular session. As of 12:40 EST, this security is trading at a volume of 97.0K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $233.8 million. </li>
<li>Trupanion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) shares increased by 6.75% to $32.73. As of 12:40 EST, Trupanion's stock is trading at a volume of 194.3K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Huize Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUIZ#NASDAQ">HUIZ</a>) stock increased by 6.15% to $0.69. Huize Holding's stock is trading at a volume of 3.7K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $34.0 million. </li>
<li>James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) stock rose 5.9% to $10.05. As of 12:40 EST, this security is trading at a volume of 136.2K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $359.8 million. </li>
<li>SelectQuote (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLQT#NYSE">SLQT</a>) stock rose 5.59% to $1.51. Trading volume for this security as of 12:40 EST is 809.6K, which is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $251.5 million. As per the press release, Q2 earnings came out 3 days ago. </li>
<li>Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) shares moved upwards by 3.97% to $12.03. The current volume of 74.0K shares is 0% of Greenlight Capital Re's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $408.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>FG Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGF#NASDAQ">FGF</a>) stock declined by 8.92% to $1.23 during Monday's regular session. The current volume of 36.2K shares is 0% of FG Finl Gr's average full-day volume over the last 100 days (last updated at 12:40 EST). The company's market cap stands at $15.3 million. </li>
<li>Tian Ruixiang Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) shares fell 7.56% to $0.58. The current volume of 29.4K shares is 0% of Tian Ruixiang Holdings's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at $1.9 million. </li>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) stock declined by 3.91% to $1.23. As of 12:40 EST, Marpai's stock is trading at a volume of 29.1K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $11.3 million. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) stock declined by 2.91% to $12.38. Trading volume for this security as of 12:40 EST is 19.5K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at 605219326. </li>
<li>Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) shares declined by 2.04% to $17.32. As of 12:40 EST, this security is trading at a volume of 1.9 million shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.9 billion. As per the press release, Q4 earnings came out 3 days ago. </li>
<li>Reliance Global Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RELI#NASDAQ">RELI</a>) shares declined by 1.59% to $0.48. As of 12:40 EST, this security is trading at a volume of 31.8K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JRVR

OSCR

TIRX

TRUP

Insurance Stocks Moving In Monday's Intraday Session

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Abacus Life (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NASDAQ">ABL</a>) shares rose 7.91% to $10.43 during Tuesday's regular session. Abacus Life's stock is trading at a volume of 34.3K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $623.9 million. </li>
<li>James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) stock moved upwards by 3.62% to $9.57. As of 12:40 EST, this security is trading at a volume of 147.9K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $345.9 million. </li>
<li>American Coastal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) shares moved upwards by 3.48% to $9.79. Trading volume for this security as of 12:40 EST is 71.0K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $421.8 million. </li>
<li>Trupanion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) stock moved upwards by 3.27% to $31.51. Trupanion's stock is trading at a volume of 313.8K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion. </li>
<li>Hallmark Financial Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALL#NASDAQ">HALL</a>) stock rose 3.07% to $1.04. As of 12:40 EST, this security is trading at a volume of 42.7K shares, making up 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.9 million. </li>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) stock increased by 2.85% to $1.8. As of 12:40 EST, Marpai's stock is trading at a volume of 9.2K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $15.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) shares declined by 4.55% to $1.05 during Tuesday's regular session. Oxbridge Re Holdings's stock is trading at a volume of 6.0K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.9 million. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) shares fell 4.13% to $12.54. Crawford's stock is trading at a volume of 24.8K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The company's market cap stands at 613041224. </li>
<li>Kingstone Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) shares declined by 3.76% to $2.05. As of 12:40 EST, Kingstone Companies's stock is trading at a volume of 14.2K, which is 0% of its average full-day volume over the last 100 days. The company's market cap stands at $26.3 million. </li>
<li>Global Indemnity Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBLI#NYSE">GBLI</a>) stock decreased by 3.22% to $31.2. Global Indemnity Group's stock is trading at a volume of 2.3K shares as of 12:40 EST. This is 0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $365.6 million. </li>
<li>Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) shares fell 3.16% to $11.06. As of 12:40 EST, this security is trading at a volume of 32.2K shares, making up 0% of its average full-day volume over the last 100 days. The company's market cap stands at $403.5 million. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) shares fell 2.32% to $12.88. The current volume of 38.4K shares is 0% of Crawford's average full-day volume over the last 100 days (last updated at 12:40 EST). The market value of their outstanding shares is at 629418322. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GBLI

HALL

OXBR

<a href="https://pro.benzinga.com/?utm_source=insights">According to Benzinga Pro</a> following are the gainers and losers in <a href="https://www.benzinga.com/money/insurance/">Insurance</a> industry for today's Intraday session. 
<h3>Gainers</h3>
<ul>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) shares moved upwards by 56.98% to $0.59 during Friday's regular session. As of 12:40 EST, Marpai's stock is trading at a volume of 26.9 million, which is 26094.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.9 million. </li>
<li>SiriusPoint (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPNT#NYSE">SPNT</a>) stock rose 4.11% to $9.99. As of 12:40 EST, this security is trading at a volume of 156.9K shares, making up 31.3% of its average full-day volume over the last 100 days. The company's market cap stands at $1.6 billion. The company's, Q3 earnings came out 2 days ago. </li>
<li>Crawford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRD#NYSE">CRD</a>) stock moved upwards by 3.16% to $10.54. As of 12:40 EST, Crawford's stock is trading at a volume of 11.8K, which is 22.4% of its average full-day volume over the last 100 days. The company's market cap stands at 515453274. As per the press release, Q3 earnings came out 4 days ago. </li>
<li>Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) stock rose 3.0% to $159.94. Trading volume for this security as of 12:40 EST is 224.6K, which is 63.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.2 billion. </li>
<li>Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) shares moved upwards by 2.53% to $10.92. Greenlight Capital Re's stock is trading at a volume of 54.3K shares as of 12:40 EST. This is 72.2% of its average full-day volume over the last 100 days. The company's market cap stands at $375.6 million. As per the news, the Q3 earnings report came out 2 days ago. </li>
<li>James River Gr Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JRVR#NASDAQ">JRVR</a>) shares moved upwards by 2.31% to $9.04. James River Gr Hldgs's stock is trading at a volume of 950.4K shares as of 12:40 EST. This is 422.5% of its average full-day volume over the last 100 days. The company's market cap stands at $348.6 million. As per the news, the Q3 earnings report came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) shares declined by 4.94% to $7.04 during Friday's regular session. As of 12:40 EST, eHealth's stock is trading at a volume of 127.6K, which is 66.6% of its average full-day volume over the last 100 days. The company's market cap stands at $207.8 million. As per the press release, Q3 earnings came out 2 days ago. </li>
<li>Abacus Life (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABL#NASDAQ">ABL</a>) stock decreased by 4.59% to $6.66. Trading volume for this security as of 12:40 EST is 596, which is 3.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $473.4 million. </li>
<li>Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) stock declined by 4.36% to $14.4. Trading volume for this security as of 12:40 EST is 1.5 million, which is 100.0% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion. </li>
<li>Waterdrop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) stock fell 4.35% to $1.1. Trading volume for this security as of 12:40 EST is 62.4K, which is 29.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $450.2 million. </li>
<li>Tian Ruixiang Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIRX#NASDAQ">TIRX</a>) stock decreased by 3.95% to $0.73. Tian Ruixiang Holdings's stock is trading at a volume of 65.2K shares as of 12:40 EST. This is 17.5% of its average full-day volume over the last 100 days. The company's market cap stands at $2.6 million. </li>
<li>GoHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOCO#NASDAQ">GOCO</a>) stock declined by 3.15% to $12.5. GoHealth's stock is trading at a volume of 1.4K shares as of 12:40 EST. This is 6.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $122.7 million. The company's, Q3 earnings came out yesterday. </li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GOCO

LMND

SPNT

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Greenlight Capital Re beat estimated earnings by 230.0%, reporting an EPS of $0.39 versus an estimate of $-0.3.
Revenue was up $40.20 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.37 which was followed by a 6.27% increase in the share price the next day.

To track all earnings releases for Greenlight Capital Re <a href="https://www.benzinga.com/quote/GLRE/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Greenlight Capital Re: Q3 Earnings Insights

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $(0.30) by 230 percent. This is a 169.64 percent increase over losses of $(0.56) per share from the same period last year. The company reported $166.92 million in sales this quarter. This is a 31.72 percent increase over sales of $126.72 million the same period last year.

Greenlight Capital Re Q3 EPS $0.39 Beats $(0.30) Estimate, Sales $166.92M Up From $126.72M YoY

Greenlight Capital Re, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) (the "Company" or "Greenlight Re"), a multiline property and casualty insurer and reinsurer, today announced that Simon Burton, the Company's Chief Executive Officer,&nbsp;has informed the Board of Directors of his intention to depart from the Company and step down as a director, effective as of December 31, 2023. In connection with Mr. Burton's impending departure, Greenlight Re announced that Greg Richardson will be appointed as the Company's new Chief Executive Officer and a member of the Board of Directors, effective as of January 1, 2024. Mr. Burton will serve as an advisor and provide transitional services through April 2024. &nbsp;
Mr. Richardson previously served as Chief Risk and Strategy Officer at TransRe from 2014 to 2023. Prior to that, he held strategic planning and underwriting roles and served as Chief Underwriting Officer at Harbor Point Re (which merged with Max Re Capital to form Alterra Re) from 2006 to 2013. Mr. Richardson graduated with a Bachelor of Science Honors degree in Mathematics from Purdue University, was a Marshall Scholar at Oxford University, and obtained his Master of Business Administration degree in Finance from the University of Chicago.
"Greg's deep expertise in the industry and experience in a number of underwriting and strategic positions, makes him uniquely suited for the Chief Executive Officer role at Greenlight Re. I am confident the team will capitalize on our significant growth opportunities with Greg at the helm," said David Einhorn, Chairman of the Board of Directors at Greenlight Re. "Greg is an exceptional leader, and the Board and I believe he is the right person to guide Greenlight Re through our next chapter."
"On behalf of the Board, I want to thank Simon for his leadership and dedication throughout his tenure at the Company. We are grateful for all he has done for Greenlight Re and wish him well in all of his future endeavors," Mr. Einhorn further stated. "We look forward to building on everything we have accomplished during Simon's tenure as the opportunities that lie ahead appear more promising than ever given the favorable reinsurance environment."

Management

Greenlight Capital Re, Ltd. Announces Simon Burton As New Chief Executive Officer Effective As Of December 31, 2023

Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) is set to give its latest quarterly earnings report on Wednesday, 2023-11-08. Here's what investors need to know before the announcement.
Analysts estimate that Greenlight Capital Re will report an earnings per share (EPS) of $-0.30. 
Greenlight Capital Re bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.37, which was followed by a 6.27% increase in the share price the next day.
Here's a look at Greenlight Capital Re's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.95</td>
<td>-0.10</td>
<td>0.75</td>
<td>0.05</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.32</td>
<td>0.17</td>
<td>0.91</td>
<td>-0.56</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.27%</td>
<td>-5.45%</td>
<td>3.62%</td>
<td>-9.09%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1699372862_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Greenlight Capital Re were trading at $11.39 as of November 06. Over the last 52-week period, shares are up 39.75%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/GLRE/earnings">To track all earnings releases for Greenlight Capital Re visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Greenlight Capital Re's Earnings Outlook

Press Releases

Greenlight Capital Re, Ltd. Schedules First Quarter 2024 Financial Results and Conference Call

Greenlight Re Announces First Quarter 2024 Financial Results

Greenlight Capital Re, Ltd. Schedules Second Quarter 2024 Financial Results and Conference Call

Greenlight Re Announces Second Quarter 2024 Financial Results

AM Best Revises Outlooks to Positive for Greenlight Capital Re, Ltd. and Its Subsidiaries

Greenlight Capital Re, Ltd. Schedules Third Quarter 2024 Financial Results and Conference Call

Greenlight Re Announces Third Quarter 2024 Financial Results

Greenlight Capital Re to Host Investor Day in New York on Tuesday, November 19, 2024

Greenlight Capital Re, Ltd. Schedules Fourth Quarter and Full Year 2024  Financial Results and Conference Call

Comments

Greenlight Capital Re

Noticias

Últimas noticias sobre Greenlight Capital Re (NASDAQ:GLRE) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL